On December 27, 2022, in United States v. Blaszczak (“Blaszczak II”), the U.S. Court of Appeals for the Second Circuit called into question what constitutes “property” in cases of securities fraud, wire fraud and theft of...more
In the case that tested the limits of the “fake it till you make it” approach to a startup business, on January 3, 2022, a jury in the U.S. District Court for the Northern District of California convicted Elizabeth Holmes,...more
1/5/2022
/ Blood Tests ,
Department of Defense (DOD) ,
False Statements ,
Fraud ,
Healthcare ,
Investors ,
Laboratories ,
Logos ,
Pharmaceutical Industry ,
Technology ,
Theranos ,
Third-Party ,
Whistleblowers ,
Wire Fraud